Aralez Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
32,827.70
43,261.20
24,815.70
64,943.00
28,892.00
Total Accounts Receivable
1,673.00
5,629.20
5,965.90
20,405.00
13,453.00
Inventories
-
-
-
4,548.00
6,643.00
Other Current Assets
794.70
583.10
1,224.70
2,435.00
3,687.00
Total Current Assets
35,295.40
49,473.50
32,006.30
92,331.00
52,675.00
Net Property, Plant & Equipment
39.00
27.40
251.30
7,316.00
7,453.00
Intangible Assets
-
-
-
416,888.00
392,127.00
Other Assets
-
-
-
842.00
1,222.00
Total Assets
35,334.40
50,453.70
32,257.60
517,377.00
453,477.00
Accounts Payable
1,500.70
606.90
4,557.10
8,833.00
23,631.00
Income Tax Payable
-
952.90
-
-
-
Other Current Liabilities
16,045.00
2,153.10
11,931.90
48,441.00
44,229.00
Total Current Liabilities
17,545.70
3,712.90
16,489.00
57,274.00
67,860.00
Long-Term Debt
-
-
-
274,441.00
274,546.00
Provision for Risks & Charges
-
-
-
60,685.00
-
Deferred Taxes
-
952.90
-
3,273.00
3,797.00
Other Liabilities
-
-
985.40
2,218.00
92,055.00
Total Liabilities
17,545.70
3,712.90
17,474.40
397,891.00
438,258.00
Common Equity (Total)
17,788.70
46,740.80
14,783.20
119,486.00
15,219.00
Total Shareholders' Equity
17,788.70
46,740.80
14,783.20
119,486.00
15,219.00
Total Equity
17,788.70
46,740.80
14,783.20
119,486.00
15,219.00
Liabilities & Shareholders' Equity
35,334.40
50,453.70
32,257.60
517,377.00
453,477.00
About Aralez Pharmaceuticals
View Profile
